These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34653731)

  • 1. Immune checkpoint molecule TIGIT manipulates T cell dysfunction in septic patients.
    Sun Y; Ding R; Chang Y; Li J; Ma X
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108205. PubMed ID: 34653731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
    Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
    Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.
    Sun Y; Anyalebechi JC; Sun H; Yumoto T; Xue M; Liu D; Liang Z; Coopersmith CM; Ford ML
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
    Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
    Front Immunol; 2020; 11():1619. PubMed ID: 32793241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
    Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
    Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia.
    Zhang X; Zhang H; Chen L; Feng Z; Gao L; Li Q
    Cell Immunol; 2019 Oct; 344():103958. PubMed ID: 31376919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
    Li C; Liu H; Duan Z
    BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
    Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
    Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
    Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbed CD8
    Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
    Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
    Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
    Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
    Dougall WC; Kurtulus S; Smyth MJ; Anderson AC
    Immunol Rev; 2017 Mar; 276(1):112-120. PubMed ID: 28258695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD226 opposes TIGIT to disrupt Tregs in melanoma.
    Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
    Liu G; Zhang Q; Yang J; Li X; Xian L; Li W; Lin T; Cheng J; Lin Q; Xu X; Li Q; Lin Y; Zhou M; Shen E
    Cancer Immunol Immunother; 2022 Feb; 71(2):277-287. PubMed ID: 34129052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataloging circulating CD3
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bueno-Topete MR; Tellez-Bañuelos MC; Haramati J; Del Toro-Arreola S
    Immunol Lett; 2024 Oct; 269():106889. PubMed ID: 38945372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8
    Whelan S; Ophir E; Kotturi MF; Levy O; Ganguly S; Leung L; Vaknin I; Kumar S; Dassa L; Hansen K; Bernados D; Murter B; Soni A; Taube JM; Fader AN; Wang TL; Shih IM; White M; Pardoll DM; Liang SC
    Cancer Immunol Res; 2019 Feb; 7(2):257-268. PubMed ID: 30659054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
    Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
    J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.